Indeed, it is possible that, in PCa, due to the loss of membranous FGFRL1, re-localized FGFRL1 fails to regulate FGFR signaling through the decoy receptor function and/or adopts other functions to promote PCa progression, as happens, for example, in ovarian cancer [27]. Here, FGFRL1 is linked to ovarian carcinoma.